Risk of second malignant neoplasms after childhood leukemia and lymphoma: an international study.

BACKGROUND Survivors of childhood leukemia and lymphoma experience high risks of second malignant neoplasms. We quantified such risk using a large dataset from 13 population-based cancer registries. METHODS The registries provided individual data on cases of leukemia, Hodgkin lymphoma, and non-Hodgkin lymphoma occurring in children aged 0-14 years and on subsequent second malignant neoplasms for different time periods from 1943 to 2000. Risks of second malignant neoplasms were assessed through standardized incidence ratios (SIRs) and corresponding 95% confidence intervals (CIs), using the incidence rates in the general populations covered by the registries as a reference. Cumulative absolute risks were also calculated. RESULTS A total of 133 second malignant neoplasms were observed in 16,540 patients (12,731 leukemias, 1246 Hodgkin lymphomas, and 2563 non-Hodgkin lymphomas) after an average follow-up of 6.5 years. The most frequent second malignancies after leukemia were brain cancer (19 cases, SIR = 8.52, 95% CI = 5.13 to 13.3), non-Hodgkin lymphoma (nine cases, SIR = 9.41, 95% CI = 4.30 to 17.9), and thyroid cancer (nine cases, SIR = 18.8, 95% CI = 8.60 to 35.7); the most frequent after Hodgkin lymphoma were thyroid cancer (nine cases, SIR = 52.5, 95% CI = 24.0 to 99.6), breast cancer (six cases, SIR = 20.9, 95% CI = 7.66 to 45.4), and neoplasms of skin (non-melanoma) (six cases, SIR = 34.0, 95% CI = 12.5 to 74.0); and the most frequent after non-Hodgkin lymphoma were thyroid cancer (six cases, SIR = 40.4, 95% CI = 14.8 to 88.0) and brain cancer (four cases, SIR = 6.97, 95% CI = 1.90 to 17.9). Cumulative incidence of any second malignant neoplasm was 2.43% (95% CI = 1.09 to 3.78), 12.7% (95% CI = 8.29 to 17.2), and 2.50% (95% CI = 1.04 to 3.96) within 30 years from diagnosis of leukemia, Hodgkin lymphoma, and non-Hodgkin lymphoma, respectively. CONCLUSIONS This population-based study provides, to our knowledge, the most precise and up-to-date estimates for relative and absolute risks of second malignant neoplasms after childhood leukemia and lymphoma.

[1]  D. Alberts.  Second Cancers Are Killing Us! , 2006, Cancer Epidemiology Biomarkers & Prevention.

[2]  L. Travis,et al.  The Epidemiology of Second Primary Cancers , 2006, Cancer Epidemiology Biomarkers & Prevention.

[3]  E. Steliarova-Foucher,et al.  Trends in survival after childhood cancer in Europe, 1978-1997: report from the Automated Childhood Cancer Information System project (ACCIS). , 2006, European journal of cancer.

[4]  S. Bhatia,et al.  Long‐term follow‐up of childhood cancer survivors: Future directions for clinical care and research , 2006, Pediatric blood & cancer.

[5]  Heikki Joensuu,et al.  Acute myeloid leukemia following Hodgkin lymphoma: a population-based study of 35,511 patients. , 2006, Journal of the National Cancer Institute.

[6]  Leslie L Robison,et al.  Risk of selected subsequent carcinomas in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  M. Gail,et al.  Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma. , 2005, Journal of the National Cancer Institute.

[8]  A. Craft,et al.  Second primary tumors in children and young adults in the North of England (1968–99) , 2005, Pediatric blood & cancer.

[9]  J. Dockerty,et al.  Population-based survival of children in New Zealand diagnosed with cancer during 1990-1993. , 2005, European journal of cancer.

[10]  Yan Liu,et al.  Primary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study): a nested case-control study , 2005, The Lancet.

[11]  Yan Liu,et al.  Nonmelanoma skin cancer in survivors of childhood and adolescent cancer: a report from the childhood cancer survivor study. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  E. Steliarova-Foucher,et al.  Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCIS project): an epidemiological study , 2004, The Lancet.

[13]  H. B. Marsden,et al.  Long-term population-based risks of second malignant neoplasms after childhood cancer in Britain , 2004, British Journal of Cancer.

[14]  M. Hawkins.  Long-term survivors of childhood cancers: what knowledge have we gained? , 2004, Nature Clinical Practice Oncology.

[15]  L. Robison,et al.  Breast Cancer after Childhood Cancer: A Report from the Childhood Cancer Survivor Study , 2004, Annals of Internal Medicine.

[16]  J. Jazbec,et al.  Second neoplasms after treatment of childhood cancer in Slovenia , 2004, Pediatric blood & cancer.

[17]  L. Kersun,et al.  Secondary malignant neoplasms of the bladder after cyclophosphamide treatment for childhood acute lymphocytic leukemia , 2004, Pediatric blood & cancer.

[18]  M. Relling,et al.  Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemia. , 2003, The New England journal of medicine.

[19]  M. Stovall,et al.  Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. , 2003, JAMA.

[20]  J. Yahalom.  Breast cancer after Hodgkin disease: hope for a safer cure. , 2003, JAMA.

[21]  J. Michaelis,et al.  Second malignant neoplasms after treatment of childhood cancer. , 2003, European journal of cancer.

[22]  M. Coleman,et al.  Childhood cancer survival in Europe and the United States , 2002, Cancer.

[23]  J. Friedberg,et al.  Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors. , 2002, Blood.

[24]  L. Robison,et al.  Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after 1983. , 2002, Blood.

[25]  L. Robison,et al.  Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study. , 2001, Journal of the National Cancer Institute.

[26]  G. Gatta,et al.  Childhood cancer survival in Europe. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

[27]  B Terracini,et al.  Childhood cancer survival in Europe: an overview. , 2001, European journal of cancer.

[28]  J. Coebergh,et al.  Survival of childhood lymphomas in Europe, 1978--1992: a report from the EUROCARE study. , 2001, European journal of cancer.

[29]  J. Coebergh,et al.  Variation in survival of European children with acute lymphoblastic leukaemia, diagnosed in 1978--1992: the EUROCARE study. , 2001, European journal of cancer.

[30]  P. Simpson,et al.  Statistical methods in cancer research , 2001, Journal of surgical oncology.

[31]  G. Masera,et al.  Early and late deaths after elective end of therapies for childhood cancer in Italy , 2000, International journal of cancer.

[32]  Mark Woodward,et al.  Epidemiology: Study Design and Data Analysis , 1999 .

[33]  J Crowley,et al.  Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. , 1999, Statistics in medicine.

[34]  J. Michaelis,et al.  Multiple primary neoplasms in childhood: data from the German Children's Cancer Registry. , 1998, European journal of cancer.

[35]  J. Ferlay,et al.  Cancer Incidence in Five Continents , 1970, Union Internationale Contre Le Cancer / International Union against Cancer.

[36]  C. Magnani,et al.  Incidence of second primary malignancies after a malignant tumor in childhood a population‐based survey in Piedmont (ITALY) , 1996, International journal of cancer.

[37]  A Kreuger,et al.  Risk of subsequent malignant neoplasms among 1,641 Hodgkin's disease patients diagnosed in childhood and adolescence: a population-based cohort study in the five Nordic countries. Association of the Nordic Cancer Registries and the Nordic Society of Pediatric Hematology and Oncology. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  H. B. Marsden,et al.  Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer. , 1996, Journal of the National Cancer Institute.

[39]  A. Hagenbeek,et al.  Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma. , 1995, Journal of the National Cancer Institute.

[40]  H. Tsukuma,et al.  Survival Rates of Childhood Cancer Patients in Osaka, Japan, 1975–1984 , 1995, Japanese journal of cancer research : Gann.

[41]  A. Kingma,et al.  Association of 1800 cGy cranial irradiation with intellectual function in children with acute lymphoblastic leukaemia , 1994, The Lancet.

[42]  J. Olsen,et al.  Second malignant neoplasms after cancer in childhood or adolescence. Nordic Society of Paediatric Haematology and Oncology Association of the Nordic Cancer Registries. , 1993, BMJ.

[43]  R. Nygaard,et al.  Second Malignant Neoplasms in Patients Treated for Childhood Leukemia: A Population‐based Cohort Study from the Nordic Countries , 1991, Acta paediatrica Scandinavica.

[44]  L. Robison,et al.  Second neoplasms after acute lymphoblastic leukemia in childhood. , 1991, The New England journal of medicine.

[45]  O. M. Jensen,et al.  Cancer Registration: Principles and Methods , 1991 .

[46]  R. Hoover,et al.  Therapeutic radiation at a young age is linked to secondary thyroid cancer. The Late Effects Study Group. , 1991, Cancer research.

[47]  C. Hill,et al.  Long-term risk of second malignant neoplasm after a cancer in childhood. , 1989, British Journal of Cancer.

[48]  N. Nissen,et al.  Carcinoma of the urinary bladder after treatment with cyclophosphamide for non-Hodgkin's lymphoma. , 1988, The New England journal of medicine.

[49]  A. Meadows,et al.  DECLINES IN IQ SCORES AND COGNITIVE DYSFUNCTIONS IN CHILDREN WITH ACUTE LYMPHOCYTIC LEUKAEMIA TREATED WITH CRANIAL IRRADIATION , 1981, The Lancet.

[50]  V. N. Slee,et al.  The International Classification of Diseases: ninth revision (ICD-9) , 1978, Annals of internal medicine.

[51]  P. Skrabanek.  Letter: Unexplained tetanic spasms. , 1974, Lancet.

[52]  J. Stockman.  Primary Thyroid Cancer After a First Tumour in Childhood (the Childhood Cancer Survivor Study): A Nested Case-Control Study , 2007 .

[53]  E. Feuer,et al.  SEER Cancer Statistics Review, 1975-2003 , 2006 .

[54]  A. Oshima,et al.  Survival rates of childhood cancer patients in Osaka, Japan. , 2004, Japanese journal of clinical oncology.

[55]  Joseph V. Simone,et al.  Childhood cancer survivorship : improving care and quality of life , 2003 .

[56]  Cancer incidence in five continents. Volume VIII. , 2002, IARC scientific publications.

[57]  A. Neugut,et al.  Multiple primary cancers , 1999 .

[58]  C. Pui.  Medical progress : childhood leukemias , 1995 .

[59]  P. Landrigan.  Childhood leukemias. , 1995, The New England journal of medicine.

[60]  P. Pizzo,et al.  Principles and Practice of Pediatric Oncology , 1989 .

[61]  N. Breslow,et al.  Statistical methods in cancer research. Volume II--The design and analysis of cohort studies. , 1987, IARC scientific publications.

[62]  J. Burchenal,et al.  Treatment of acute lymphoblastic leukemia. , 1972, Annual review of medicine.

[63]  Rascon.  [The National Cancer Institute]. , 1953, Boletin cultural e informativo - Consejo General de Colegios Medicos de Espana.